Corise Cardiopet TEL Suspension is a prescription-only veterinary medication specifically engineered for the targeted management of systemic hypertension (high blood pressure) and the protection of renal health in feline patients. The active pharmaceutical ingredient, Telmisartan, operates as a highly selective Angiotensin II Receptor Blocker (ARB). By specifically blocking the AT1 receptor subtype, it prevents angiotensin II from constricting blood vessels, thereby promoting smooth arterial dilation and smoothly lowering blood pressure without causing dangerous reflex tachycardia.

Beyond its foundational cardiovascular benefits, Cardiopet TEL delivers critical renoprotective actions by decreasing intraglomerular pressure and significantly reducing proteinuria (the loss of vital proteins through the urine). This makes it an invaluable first-line therapy for cats suffering from Chronic Kidney Disease (CKD) alongside secondary hypertension. Formulated as a highly palatable liquid oral suspension, it is designed with an easy-to-use measuring syringe for exact micro-dosing based on body weight. This format allows pet owners to seamlessly administer routine daily doses directly into the cat's mouth or over food, eliminating the stress and anxiety associated with forcing solid tablets.